Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2003
09/25/2003US20030181458 Preferential serotonin receptors antagonists comprising heterocyclic amines used for prophylaxis or prevention of headaches, sleep, sexual or eating disorders and as antidepressants
09/25/2003US20030181444 Heterocyclic amines such as 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one, used as antiserotonine agents
09/25/2003US20030181427 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
09/25/2003US20030181422 Cardioprotective phosphonates and malonates
09/25/2003US20030181420 Modulators of LXR
09/25/2003US20030181397 Synergistic composition of bioactive fraction isolated barleria prionitis linn and a method of treatment for hepatotoxicity, immuno-deficiency and fatigue and a process thereof
09/25/2003US20030181389 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
09/25/2003US20030181388 Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire
09/25/2003US20030181379 Novel fibroblast growth factor (FGF23) and methods for use
09/25/2003US20030181364 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions.
09/25/2003US20030181352 Substituted heterocyclic compounds
09/25/2003US20030180934 Plasminogen-like polynucleotides, polypeptides, and antibodies
09/25/2003US20030180901 Medicinal compositions for promoting recovery from stress loading and novel matsutake mushroom strain
09/25/2003US20030180877 Gene therapy; drug screening
09/25/2003US20030180813 Method of screening remedy for diabetes
09/25/2003US20030180810 For diagnosis, prevention, and treatment of reproductive disorders, Alzheimer's disease, cancer, immunological disorders, and diabetes
09/25/2003US20030180805 Methods and compositions for derepression of IAP-inhibited caspase
09/25/2003US20030180712 Host cells transfected with a recombinant expression vector containing nucleic acid control sequences operatively linked to an L-type Ca2+ channel beta 3 gene; host cell free of functional beta 3 subunit-containing L-type Ca2+ channels
09/25/2003US20030180406 Treatment of diseases involving defective gap junctional communication
09/25/2003US20030180404 Methods of treating clinical diseases with isoflavones
09/25/2003US20030180396 Central nervous system disorders; screening for allergens
09/25/2003US20030180362 Multi-stage oral drug controlled-release system
09/25/2003US20030180360 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
09/25/2003US20030180345 Antidiabetic agents; administering mixture of amino acid and carrier
09/25/2003US20030180306 Controlling cell differentiation; muscular disorders
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180288 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
09/25/2003US20030180276 Nutrient, foods
09/25/2003US20030180273 Microorganisms for treatment or prevention of corpulence and diabetes mellitus, and pharmaceutical composition containing the same
09/25/2003US20030180271 Reduce concentration of (mono or di)saccharide absorbed by human body; forming polysaccharides in presence of microorganism
09/25/2003US20030180269 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
09/25/2003US20030180246 Free-flowing anionic surfactant, alkanolamide and electrolytemixture
09/25/2003CA2488928A1 Method of modulating inflammatory response
09/25/2003CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003CA2479141A1 Pyridone derivatives
09/25/2003CA2478997A1 Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
09/25/2003CA2478805A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
09/25/2003CA2478795A1 Use of rapamycin for inhibiting cell death
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/25/2003CA2478211A1 Nk1 antagonists
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/25/2003CA2476906A1 Compositions for treating diabetes
09/24/2003EP1346994A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds
09/24/2003EP1346993A1 Lactam compounds and medicinal use thereof
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/24/2003EP1346726A1 Sympathetic-activating perfume composition
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1346032A2 Method for the production of carbohydrates
09/24/2003EP1345979A2 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345942A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
09/24/2003EP1345938A1 Tricyclic crf receptor antagonists
09/24/2003EP1345935A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/24/2003EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345930A2 Pharmaceutical compounds
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345924A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345916A1 Substituted oxazoles and thiazoles as hppar alpha agonists
09/24/2003EP1345903A1 Crystalline forms of cerivastatin sodium
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345896A1 Crystalline forms of atorvastatin
09/24/2003EP1345895A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003EP1345629A2 Particles for inhalation having sustained release properties
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345616A2 Reducing cellular damage in the human body
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP1345600A1 New clinical treatment
09/24/2003EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity
09/24/2003EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof
09/24/2003EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1080055B1 24-hydroxyvitamin d, analogs and uses thereof
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003EP1043308B1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
09/24/2003EP0847278B1 Analogs of parathyroid hormone
09/24/2003CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses
09/24/2003CN1444659A Koji molds and use thereof for preparing cholesterol-lowering products
09/24/2003CN1444601A Regulating lipid levels via the Zmaxl or HBM gene
09/24/2003CN1444600A Use of ADNF polypeptides for enhancing learning and memory
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444580A Method for producing lipoic acid and dihydrolipoic acid
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
1 ... 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 ... 1298